Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
ZANTE GREG | Chief Financial Officer | May 03 '24 | Option Exercise | 4.86 | 34,249 | 166,285 | 241,610 | May 03 08:51 PM | ZANTE GREG | Chief Financial Officer | May 03 '24 | Sale | 74.69 | 66,756 | 4,986,008 | 174,854 | May 03 08:51 PM | Mancini Marianna | Chief Operating Officer | May 01 '24 | Option Exercise | 6.18 | 281,425 | 1,740,575 | 629,933 | May 02 09:27 PM | Mancini Marianna | Chief Operating Officer | May 01 '24 | Sale | 78.66 | 281,425 | 22,136,474 | 348,508 | May 02 09:27 PM | Lian Brian | President & CEO | Feb 09 '24 | Sale | 29.90 | 45,000 | 1,345,500 | 2,139,882 | Feb 09 08:59 PM | Lian Brian | President & CEO | Feb 08 '24 | Option Exercise | 3.76 | 189,079 | 711,367 | 2,404,882 | Feb 08 07:40 PM | Rouan Sarah Kathryn | Director | Feb 08 '24 | Option Exercise | 8.32 | 25,000 | 208,000 | 25,000 | Feb 08 07:38 PM | Lian Brian | President & CEO | Feb 08 '24 | Sale | 26.87 | 269,079 | 7,230,784 | 2,184,882 | Feb 08 07:40 PM | Rouan Sarah Kathryn | Director | Feb 08 '24 | Sale | 28.05 | 25,000 | 701,250 | 0 | Feb 08 07:38 PM | Lian Brian | President & CEO | Jan 31 '24 | Option Exercise | 1.23 | 85,000 | 104,550 | 2,349,882 | Jan 31 08:39 PM | Lian Brian | President & CEO | Jan 31 '24 | Sale | 24.71 | 85,000 | 2,100,750 | 2,264,882 | Jan 31 08:39 PM | Lian Brian | President & CEO | Jan 30 '24 | Option Exercise | 1.23 | 35,000 | 43,050 | 2,299,882 | Jan 30 09:05 PM | Lian Brian | President & CEO | Jan 30 '24 | Sale | 23.95 | 35,000 | 838,250 | 2,264,882 | Jan 30 09:05 PM | Rouan Sarah Kathryn | Director | Jan 19 '24 | Option Exercise | 8.32 | 30,000 | 249,600 | 30,000 | Jan 19 08:35 PM | Rouan Sarah Kathryn | Director | Jan 19 '24 | Sale | 23.05 | 30,000 | 691,500 | 0 | Jan 19 08:35 PM | ZANTE GREG | Chief Financial Officer | Jan 04 '24 | Sale | 17.90 | 15,000 | 268,500 | 180,730 | Jan 04 09:35 PM | Rowland Charles A Jr | Director | May 16 '23 | Option Exercise | 1.08 | 40,000 | 43,200 | 70,000 | May 18 06:31 PM | MACARTNEY LAWSON | Director | May 16 '23 | Option Exercise | 1.19 | 16,000 | 19,040 | 63,965 | May 18 06:30 PM | Rowland Charles A Jr | Director | May 16 '23 | Sale | 25.00 | 40,000 | 1,000,000 | 30,000 | May 18 06:31 PM | MACARTNEY LAWSON | Director | May 16 '23 | Sale | 24.00 | 16,000 | 384,000 | 47,965 | May 18 06:30 PM |
|